Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-031028
Filing Date
2025-08-14
Accepted
2025-08-14 07:21:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A ef20053872_defa14a.htm DEFA14A 200481
2 image00001.jpg GRAPHIC 2828
  Complete submission text file 0001140361-25-031028.txt   205694
Mailing Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183
Business Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40493 | Film No.: 251214305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)